Elevance Health Inc. (ELV) Tops Q2 EPS by 30c

Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $8.04, $0.30 better than the analyst estimate of $7.74. Revenue for the quarter came in at $38.5 billion versus the consensus estimate of $37.92 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group